Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver?

about

Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver?

Item

http://www.wikidata.org/entity/Q45072672

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Does the enterolactone (ENL) a ...... and lipid metabolism in liver?

@en

Does the enterolactone

@nl

type

Item

label

Does the enterolactone (ENL) a ...... and lipid metabolism in liver?

@en

Does the enterolactone

@nl

prefLabel

Does the enterolactone (ENL) a ...... and lipid metabolism in liver?

@en

Does the enterolactone

@nl

P1476

Does the enterolactone (ENL) a ...... and lipid metabolism in liver?

@en

P2093

Klaudia Berk

http://www.w3.org/2001/XMLSchema#string

Krzysztof Drygalski

http://www.w3.org/2001/XMLSchema#string

Nicoletta Iłowska

http://www.w3.org/2001/XMLSchema#string

Tomasz Charytoniuk

http://www.w3.org/2001/XMLSchema#string

P2860

Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells

A simple method for the isolation and purification of total lipides from animal tissues

Recent insights into the biological functions of liver fatty acid binding protein 1

AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes

Comparative Studies of Vertebrate Platelet Glycoprotein 4 (CD36)

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial.

The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects.

Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan.

NAFLD, NASH and liver cancer.

P2888

s12986-017-0223-1

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12986-017-0223-1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Adrian Chabowski

Bartłomiej Łukaszuk

Karolina Konstantynowicz-Nowicka

P577

2017-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092655652

http://www.w3.org/2001/XMLSchema#string

P698

29158770

http://www.w3.org/2001/XMLSchema#string

P921

fatty acid

P932

5683590

http://www.w3.org/2001/XMLSchema#string